A client with breast cancer has had genetic testing that shows she is a CYP2D6 ultra-rapid metabolizer.How would the nurse explain this result?
A) "You do not have the functional enzyme to break down tamoxifen."
B) "Your ability to break tamoxifen down to active metabolites is normal."
C) "Your body will break down tamoxifen to its active metabolites very quickly,which increases your ability to fight your cancer."
D) "You will break tamoxifen down so quickly that it will be metabolized out of your system before it can work on cancer cells."
Correct Answer:
Verified
Q5: Which way of encouraging use of pharmacogenetic
Q6: A client is having genetic testing done
Q7: The nurse is discussing the current use
Q8: Which statement by a newly licensed nurse
Q9: The prescriber who follows the latest research
Q10: The nurse is evaluating the appropriateness of
Q11: The nurse will be responsible for the
Q12: A client asks the nurse how something
Q13: A prescriber is considering pharmacogenetic testing (PGx)for
Q14: The benefits of pharmacogenetics (PGx)are documented.Which reasons
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents